Mr. Hu is primarily responsible for participating in formulating our Company’s corporate and business strategies.
Mr. Hu has over 13 years of experience in investment management, strategic consulting and operations management in the biomedicine industry. He joined Qiming Weichuang Venture Capital Management (Shanghai) Co. Ltd in November 2006 and is currently a managing partner of the firm. Mr. Hu is also a director of Shanghai Sanyou Medical Technology Co., Ltd. and Amoy Diagnostics Co., Ltd.. From December 2014 to April 2018, Mr. Hu also served as a non-executive director of BBI Life Sciences Corporation. Mr. Hu has also been a director of Antengene Zhejiang since July 2017.
Mr. Hu graduated from Shanghai Medical University (now Fudan University Shanghai Medical College ) with a Bachelor’s degree in medicine in July 1998. He obtained his Master’s degree of business administration in international management from Ecole Nationale des Ponts et Chaussées (now École des Ponts ParisTech) School of International Management in October 2004.